A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Objective: This study aimed to measure and compare the effectivity and cost of the two types of ceftriaxone to determine the more cost-effectivetreatment.Methods: In a cross-sectional analytical study, prescription and administrative financial data were retrospectively collected using the total samplingmethod. Data of 63 patients, comprising 43 and 20 patients treated with generic and patent ceftriaxone, respectively, were analyzed. The effectivenessof the treatment was measured in terms of thedoi:10.22159/ijap.2018.v10s1.16 fatcat:c46eh3hjfra3hfjkgcm23yxcja